Tokenized stock trading on Robinhood Chain exploded, reaching $70 million in daily volume, a 5x increase in two weeks. With quarterly earnings this week, investors assess whether the on‑chain RWA pivot can boost HOOD’s valuation.
Eightco Holdings (NASDAQ: ORBS) disclosed a $406M treasury split across cash, private AI stakes, and digital assets. The release raises questions about valuation transparency, liquidity, and the company's evolving role as a hybrid investment vehicle.
With five AI names—including private SpaceX—dominating the Robinhood Investor Index, analysts warn that retail investors may be dangerously under-diversified, raising concentration risks reminiscent of past market manias.
Polymarket’s onshore pivot injects fresh competition into the prediction market sector, leveraging a newly acquired derivatives license and a major marketing push to fight Kalshi and Robinhood for early-mover advantage in event-based contracts.
Source: newsday.com · journalgazette.net
The SpaceX IPO’s 19% first-day pop delivered paper gains, but sky-high demand meant retail fill rates averaged 1.5–3.5%. Broker flipping restrictions now pit quick profits against future IPO access, with a lockup overhang adding to the calculus.
Source: Miamiherald · Sacbee
SpaceX's IPO became history's largest, raising $75B and pushing its market cap to $2.7T, making Elon Musk the world's first trillionaire. The stock's explosive debut signals strong investor appetite for space ventures.
Source: TechCrunch · TechCrunch
The largest IPO ever delivered a 30% first-day pop, creating Elon Musk as the first trillionaire. Heavy trading and Robinhood traffic records highlight retail mania, but merger talk with Tesla injects volatility.
Source: TechCrunch · TechCrunch
Coinbase’s new AI agent can autonomously trade crypto and pay for premium research via the x402 protocol, setting the stage for a battle with Robinhood in retail automated investing. The move could boost trading volume and subscription revenue, and COIN stock rose 2.1% as markets applaud the expansion.
Source: TechCrunch · TechCrunch
Apple has executed five strategic stock splits since 1987 to maintain liquidity and ensure its shares remain accessible to retail investors. These maneuvers have played a critical role in the company's capital structure, facilitating employee equity programs and massive share buyback initiatives.
Source: Sacbee · Kansascity
While prediction markets like Polymarket offer high-engagement binary outcomes, analysts argue they lack intrinsic value compared to the tangible growth of the AI infrastructure sector. Investors are increasingly looking toward picks-and-shovels plays like Brookfield Renewable Partners and Digital Realty to capitalize on the massive energy and data demands of the artificial intelligence build-out.
ARK Invest has solidified its top stock selections for 2026, centering its strategy on the convergence of artificial intelligence, blockchain, and autonomous technology. CEO Cathie Wood continues to prioritize disruptive innovation, doubling down on fintech and AI infrastructure despite broader market volatility.
Source: insidermonkey.com · insidermonkey.com
Robinhood's new $658 million venture-focused fund, designed to provide retail investors access to high-growth private startups like Stripe and SpaceX, saw its shares tumble 11% in its NYSE debut. The lackluster performance highlights the valuation gap between private unicorn pricing and public market liquidity.
Source: The Tech Buzz · TechCrunch
YieldMax has announced its latest monthly dividend distributions for several of its popular option income strategy ETFs, including those tracking JPMorgan, ExxonMobil, and Robinhood. The payouts reflect the volatility-harvesting nature of the funds, with the Robinhood-linked ETF leading the group in distribution size.
Source: Seeking Alpha · Seeking Alpha
Analysts have identified two specific stocks within Robinhood's top 10 most-held assets as 'best buys,' signaling a rare alignment between retail sentiment and institutional valuation. This convergence suggests that certain high-growth tech and consumer staples favored by younger investors are now entering a phase of fundamental attractiveness for professional money managers.
Source: fool.com · finance.yahoo.com
The equity markets are navigating a complex landscape of 'sell-the-news' reactions and extreme biotech volatility following a series of clinical and financial updates. While Compass Pathways surged on positive trial results, Ocular Therapeutix and Genmab faced significant selling pressure despite reaching key milestones.
Source: Rttnews · Rttnews